当前位置:首页 - 行情中心 - 华厦眼科(301267) - 财务分析 - 现金流量表

华厦眼科

(301267)

  

流通市值:65.67亿  总市值:167.75亿
流通股本:3.29亿   总股本:8.40亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,117,596,954.171,061,368,544.314,161,488,276.513,229,641,726.39
  收到其他与经营活动有关的现金45,815,66614,112,085.63131,178,870.8785,064,810.97
  经营活动现金流入小计2,163,412,620.171,075,480,629.944,292,667,147.383,314,706,537.36
  购买商品、接受劳务支付的现金662,441,781.97287,644,395.081,296,889,934.08990,292,500.19
  支付给职工以及为职工支付的现金691,814,045.44367,405,630.31,293,462,886.33993,692,137.71
  支付的各项税费122,775,961.9347,003,438.5258,369,382.91202,128,360.94
  支付其他与经营活动有关的现金262,507,647.44148,827,190.24623,646,122.78454,838,059.28
  经营活动现金流出小计1,739,539,436.78850,880,654.123,472,368,326.12,640,951,058.12
  经营活动产生的现金流量净额423,873,183.39224,599,975.82820,298,821.28673,755,479.24
二、投资活动产生的现金流量:
  收回投资收到的现金0085,995,00085,995,000
  取得投资收益收到的现金28,384,222.658,610,441.2382,415,805.1954,011,352.2
  处置固定资产、无形资产和其他长期资产收回的现金净额267,168.8933,229.412,366,863.731,389,201.54
  处置子公司及其他营业单位收到的现金净额--1,556,308.92-
  收到的其他与投资活动有关的现金4,318,310,2091,578,999,981.577,914,000,0004,269,652,335.87
  投资活动现金流入小计4,346,961,600.541,587,643,652.218,086,333,977.844,411,047,889.61
  购建固定资产、无形资产和其他长期资产支付的现金122,448,739.1659,521,568.88279,590,030.24215,719,346.88
  投资支付的现金57,370,00039,170,00015,354,00023,244,000
  取得子公司及其他营业单位支付的现金70,147,340.762,830,709.74421,408,756.96414,751,092.83
  支付其他与投资活动有关的现金6,626,700,0004,247,700,0008,117,482,739.726,810,500,000
  投资活动现金流出小计6,876,666,079.924,349,222,278.628,833,835,526.927,464,214,439.71
  投资活动产生的现金流量净额-2,529,704,479.38-2,761,578,626.41-747,501,549.08-3,053,166,550.1
三、筹资活动产生的现金流量:
  吸收投资收到的现金190,000190,00014,831,0005,131,000
  其中:子公司吸收少数股东投资收到的现金190,000190,00014,831,0005,131,000
  筹资活动现金流入小计190,000190,00014,831,0005,131,000
  偿还债务支付的现金6,000,000021,242,3846,682,384
  分配股利、利润或偿付利息支付的现金39,266,280.210,053,451.33125,179,492.09122,155,776.99
  其中:子公司支付给少数股东的股利、利润39,266,280.210,053,451.3333,064,825.7330,450,145.39
  支付其他与筹资活动有关的现金128,160,907.2561,519,884.58374,561,418.44315,299,252.54
  筹资活动现金流出小计173,427,187.4571,573,335.91520,983,294.53444,137,413.53
  筹资活动产生的现金流量净额-173,237,187.45-71,383,335.91-506,152,294.53-439,006,413.53
五、现金及现金等价物净增加额-2,279,068,483.44-2,608,361,986.5-433,355,022.33-2,818,417,484.39
  加:期初现金及现金等价物余额3,469,541,313.463,469,577,837.553,902,896,335.793,902,896,335.79
  期末现金及现金等价物余额1,190,472,830.02861,215,851.053,469,541,313.461,084,478,851.4
补充资料:
  净利润300,327,698.5-428,215,139.12-
  资产减值准备1,590,220.58-14,220,191.65-
  固定资产和投资性房地产折旧82,244,771.59-159,489,339.44-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧82,244,771.59-159,489,339.44-
  无形资产摊销6,067,954.72-10,236,628.84-
  长期待摊费用摊销34,043,680.21-68,944,400.06-
  处置固定资产、无形资产和其他长期资产的损失-2,484,168.56--3,490,695.43-
  固定资产报废损失467,719.38-787,666.25-
  公允价值变动损失-5,060,138.1-5,086,595.9-
  财务费用22,144,921.01-44,681,094.69-
  投资损失-21,854,808.39--70,849,092.93-
  递延所得税-5,314,652.79--12,001,164.08-
  其中:递延所得税资产减少-6,128,707.7--13,854,595.33-
    递延所得税负债增加814,054.91-1,853,431.25-
  存货的减少-49,808,336.75-56,956,780.13-
  经营性应收项目的减少-25,654,282.14-330,573,585.55-
  经营性应付项目的增加-5,627,749.03--363,648,353.2-
  现金的期末余额1,190,472,830.02-3,469,541,313.46-
  减:现金的期初余额3,469,541,313.46-3,902,896,335.79-
  现金及现金等价物的净增加额-2,279,068,483.44--433,355,022.33-
公告日期2025-08-252025-04-282025-04-282024-10-29
审计意见(境内)标准无保留意见
TOP↑